Erysipelothrix rhusiopathiae is the causative agent of animal erysipelas and human erysipeloid. Some pathogenic bacteria are able to recruit host plasminogen and then use the plasminogen system for migration across tissue barriers or for nutritional demands during infection. However, there is no study on E. rhusiopathiae recruitment of plasminogen. SpaA has long been known to be a major protective antigen of E. rhusiopathiae, but its roles in virulence have not yet been well clarified. The aim of this study was to detect the activity of E. rhusiopathiae to recruit host plasminogen and evaluate the ability of SpaA to act as a receptor in the recruitment process. It was found that E. rhusiopathiae could recruit host plasminogen. SpaA could specifically bind host plasminogen. Anti-SpaA serum could significantly decrease the activity of E. rhusiopathiae to recruit plasminogen. In addition, this binding activity was lysine dependent. In conclusion, E. rhusiopathiae was able to recruit host plasminogen via SpaA. To our knowledge, this is the first report on E. rhusiopathiae recruitment of host plasminogen and the receptor in the process.
INTRODUCTION
Erysipelothrix rhusiopathiae is a small Gram-positive, slender and straight rod-shaped (0.2-0.4 by 0.8-2.5 μm) bacterium that can cause erysipelas in swine and other animals (Wood and Henderson 2006) . Erysipelothrix rhusiopathiae is also a zoonotic pathogen in humans (Gan 2005; Wang, Chang and Riley 2010) and is the causative agent of a skin disease, erysipeloid (Wood and Henderson 2006; Wang, Chang and Riley 2010) . Multilocus sequence typing analysis and genomic analysis of different strains/isolates demonstrate that E. rhusiopathiae is a weakly clonal species (Janβen et al. 2015; Forde et al. 2016) , and E. rhusiopathiae is suggested to have common reservoirs, pathogenic pathways and immunogenic properties (Janβen et al. 2015) . Clinical manifestations in humans are also highly similar to those in swine (Wang, Chang and Riley 2010) .
Erysipelothrix rhusiopathiae strains vary considerably in virulence (Gan 2005; Wood and Henderson 2006; Xuan 2010) , and no toxin has been associated with this organism (Wood and Henderson 2006; Wang, Chang and Riley 2010) . Several candidate virulence factors have been identified, including neuraminidase (Krasemann and Muller 1975) , capsular antigens (Shimoji et al. 1994) , RspA and RspB (Shimoji et al. 2003) , SpaA (Harada et al. 2014) , and the 64-66 kDa antigen (Galan and Timoney 1990) . However, different studies are contradictory (Shimoji et al. 2002; Janβen et al. 2015; Li et al. 2016) , and none of the candidate virulence factors has been demonstrated to play critical role in pathogenesis (Wang, Chang and Riley 2010) . The mechanism by which E. rhusiopathiae induces disease processes is still not clearly understood (Wood and Henderson 2006) . Some pathogenic bacteria are able to recruit host plasminogen and then use the plasminogen system for migration across tissue barriers or for nutritional demands during infection (Lahteenmaki, Edelman and Korhonen 2005; Sanderson-Smith et al. 2012) . However, there is no study on E. rhusiopathiae recruitment of plasminogen. SpaA (surface protective antigen A) has long been known to be a major protective antigen of E. rhusiopathiae (Shi et al. 2013; Harada et al. 2014 ). The C-terminal region of SpaA is very similar to the choline-binding proteins of Streptococcus pneumoniae, which can bind to choline residues of cell wall teichoic acid or lipoteichoic acid (Harada et al. 2014) . Recent studies demonstrated that SpaA plays important roles in E. rhusiopathiae adhesion to host cells and inhibition of complement-mediated killing (Harada et al. 2014; Borrathybay et al. 2015) . However, it is not known whether SpaA has other virulence roles. The aim of this study was to detect the activity of E. rhusiopathiae to recruit host plasminogen and evaluate the ability of SpaA to act as a receptor in the recruitment process.
MATERIAL AND METHODS

Bacterial strains and culture conditions
Three Erysipelothrix rhusiopathiae virulent strains SE38, GX052 and C43-5 were used in this study. They were all isolated from pigs died from acute swine erysipelas, and their virulence has been confirmed using mouse pathogenicity test (Li et al. 2015; Zhu et al. 2016 Zhu et al. , 2017 . In these experiments, E. rhusiopathiae was grown in tryptic soy broth (BD, Franklin Lake, NJ, USA) medium containing 10% bovine serum albumin (BSA; Sijiqing, Hangzhou, Zhejiang, China). The Escherichia coli strain BL21 (DE3) (TransGene, Beijing, China) was used in the expression experiments. Escherichia coli was grown in Luria-Bertani broth) or on agar plates. Kanamycin (50 μg/ml; Biosharp, Hefei, Anhui, China) was used in the growth media when required.
Detection of Erysipelothrix rhusiopathiae plasminogen-binding activity
The plasminogen-binding activity of the E. rhusiopathiae cells was detected as previously described (Jobin et al. 2004 ) with minor modifications. Erysipelothrix rhusiopathiae cells (10 9 CFU/well) were incubated in porcine plasma (1/10) or human plasminogen (5 μg/ml) at 37
• C with gentle shaking for 2 h. Then the cells were harvested by centrifugation (10 000×g for 15 min), washed three times to remove any residual plasminogen and suspended in 1 ml phosphate-buffered saline. Human urokinase (0.25 U; Yuanyebio, Shanghai, China) was added to 100 μl of the suspended bacterial cells prior to addition of 50 μg of the plasminspecific chromogenic substrate (chromogenic peptide Val-LeuLys-p-nitroanilide) (Sigma). Negative controls were performed where incubation steps with porcine plasma (human plasminogen) or urokinase were omitted. The mixture was incubated at 37 • C for 6 h, and A405 was measured.
Cloning, expression and purification of recombinant Erysipelothrix rhusiopathiae SpaA (rSpaA) and preparation of anti-rSpaA serum
The SpaA open reading frame was identified from the genome of the Fujisawa strain of E. rhusiopathiae (Ogawa et al. 2011 ).
The primers spaA-seqF and spaA-seqL (Table S1 , Supporting Information) were designed for cloning and sequencing SpaA gene of SE38 strain. The primers spaA-F (introduced BamHI site) and spaA-L (introduced XhoI site) (Table S1 ) were designed for cloning and expressing the SpaA gene of SE38 strain. Genomic DNA extraction and PCR amplification were performed as previously described (Zhu et al. 2013 (Zhu et al. , 2016 . The truncated SpaA gene sequence (88 to 1437, gene sequences of signal peptide and choline-binding repeats were truncated) was cloned into pET28a (+) using the BamHI and XhoI sites. The plasmid pET-28a-SpaA was introduced into E. coli BL21(DE3) and induced by isopropyl β-D-1-thiogalactopyranoside (final concentration 1 mM) at 37
• C overnight. The His-tagged fusion protein was purified by His-Trap chromatography according to the manufacturer's protocols (GE Healthcare, Little Chalfont, Buckinghamshire, UK). Protein-containing fractions were determined by sodium dodecyl sulfate polyacrylamide gel electropheresis (SDS-PAGE) (10% polyacrylamide gel) followed by Coomassie blue staining. Polyclonal serum against rSpaA was prepared by immunizing mice as previously described (Zhang et al. 2009 ). The animal experiment was performed according to protocols approved by the Hubei Provincial Animal Care and Use Committee (approval number 00010925). Female 28-day-old BALB/c mice each was intraperitoneal injected with ∼50 μg of rSpaA emulsified with Freund complete adjuvant (1:1). After 2 weeks, each mouse received one booster injection with the same antigen concentration emulsified with Freund incomplete adjuvant (1:1). Serum samples were collected when the booster injection was administered 10 days later.
Analysis of plasminogen-binding activity of Erysipelothrix rhusiopathiae SpaA
Enzyme-linked immunosorbent assay (ELISA) was performed to detect porcine plasminogen-binding activity of E. rhusiopathiae SpaA (Floden, Watt and Brissette 2011) . First, 96-well microtiter plates were coated with 1 μg of rSpaA and incubated overnight at 4
• C. After three washes with phosphate-buffered-saline-Tween (PBST), 200 μl of 1% (w/v) BSA in PBST was added to each well and incubated for 1 h to prevent non-specific binding. Then, the wells were incubated with 50 μl of porcine plasma at 37
• C for 2 h.
After several washes with PBST, 0.25 U of urokinase and 50 μg of the plasmin-specific chromogenic substrate (chromogenic peptide Val-Leu-Lys-p-nitroanilide) was added in. Negative controls were performed where incubation steps with porcine plasma, urokinase or rSpaA were omitted. Optical densities of the wells were measured at 405 nm in the ELISA reader. Far western blot assays were used to detect human plasminogen-binding activity of E. rhusiopathiae SpaA (Jones and Holt 2007; Esgleas et al. 2008) . After SDS-PAGE, 10 μg of rSpaA was transferred onto nitrocellulose (NC) membranes. BSA (10 μg) was used as a negative control. Then, the NC membranes were blocked with 5% skim milk in Tris-buffered-saline-Tween (TBST) with shaking at room temperature for 1 h. Next, the NC membranes were incubated with 10 μg/ml of human plasminogen (Sigma). After washing five times with TBST, the membranes were incubated with rabbit anti-plasminogen polyclonal antibody (Boster, Wuhan, Hubei, China, 1:250) with shaking at room temperature for 1 h. After washing, the membranes were incubated with goat anti-rabbit IgG-HRP (KPL, 1:5000) with shaking at room temperature for 1 h. After washing three times with TBST, the membranes were detected using an ECL kit (Advansta, Menlo Park, CA, USA).
Inhibition assay of Erysipelothrix rhusiopathiae plasminogen-binding activity
Erysipelothrix rhusiopathiae cells (10 9 CFU/well) were incubated with anti-rSpaA serum (1/100) or preimmune serum (1/100) at 37
• C with gentle shaking for 2 h. After three washes, the cells were suspended in porcine plasma (1/10) or human plasminogen (5 μg/ml) and gently shaked at 37
• C for 2 h. Then the bacterial cells were washed and mixed with urokinase (0.25 U) and plasmin-specific chromogenic substrate (chromogenic peptide Val-Leu-Lys-p-nitroanilide, 50 μg). At last, A405 was measured after the mixtures were incubated at 37 • C for 3 h.
Detection of lysine analog effect on plasminogen-binding activity of Erysipelothrix rhusiopathiae
To address the importance of SpaA lysine residues in the binding of rSpaA with plasminogen, competition binding assays were performed using the lysine analogue ε-aminocaproic acid (EACA) (Jobin et al. 2004) . Briefly, 96-well microtiter plates were coated with 1 μg of SpaA overnight at 4
• C and blocked with 1%
(w/v) BSA. Next, 200 ng human plasminogen or plasminogen mixed with 100 mM EACA and rabbit anti-plasminogen IgG as a primary antibody. Color reactions were developed and optical densities of the wells were measured at 630 nm in the ELISA reader (Luo et al. 2009 ). The optical densities of EACA-treated group were compared with normal group.
Statistical analysis
All experiments were performed at least three times with different samples in triplicate. All numerical data presented here are expressed as the means ± SD. Statistical significance was determined using Student's t-test. Differences were considered significant at a value of P < 0.05.
RESULTS
Erysipelothrix rhusiopathiae recruitment of plasminogen,
Erysipelothrix rhusiopathiae SE38 strain cells coated with porcine plasma or human plasminogen exhibited plasmin activity when activated by urokinase. The optical densities of mixture of E. rhusiopathiae cells coated with porcine plasma or human plasminogen, urokinase and plasmin-specific chromogenic substrate were significantly higher (∼3.0: ∼0.75) than negative controls where incubation steps with porcine plasma (human plasminogen) or urokinase were omitted (Fig. 1) . This result demonstrated that E. rhusiopathiae SE38 strain could bind porcine and human plasminogen. Another two E. rhusiopathiae SE38 strains also exhibited capacity to bind porcine and human plasminogen (Fig. S1 , Supporting Information). 
Obtention of recombinant Erysipelothrix rhusiopathiae
SpaA and anti-rSpaA serum
SpaA gene (Genbank accession number KX988262) of E. rhusiopathiae SE38 strain was identical to that of the Fujisawa strain. SpaA was modified to produce an N-terminal (His) 6 -tag rSpaA in E. coli and was successfully cloned and expressed, with an apparent molecular weight of ∼60 kDa (Fig. S2 , Supporting Information). Then anti-rSpaA serum was successfully gained after booster immunization.
Plasminogen-binding activity of rSpaA
The optical densities of experimental wells were significantly higher than negative controls where incubation steps with porcine plasma, urokinase or rSpaA were omitted ( Fig. 2A) . In far western blot assays, a binding band of 60 kDa was found in rSpaA lane, whereas no specific band was observed in the BSA lane (Fig. 2B) . rhusiopathiae. Groups 1 and 2, E. rhusiopathiae cells were incubated with 1/100 dilutions of anti-rSpaA serum or preimmune serum, then coated with porcine plasma (human plasminogen), activated by urokinase and detected using plasmin-specific substrate. Three independent experiments were performed in triplicate. The error bars indicate the standard deviations (SD) from three independent experiments. 
Recruitment inhibition assay
Plasmin activity of E. rhusiopathiae cells coated with porcine plasma or human plasminogen decreased significantly (∼from 2.8 or 2.28 to 2.6 or 2.0) when they were pre-incubated with antiSpaA serum (Fig. 3) .
Roles of SpaA lysine residues in plasminogen binding
The optical densities of wells incubated with plasminogen mixed with EACA were significantly different from that not mixed with EACA (Fig. 4) . The optical densities of positive control group were ∼2.1, whereas the optical densities (∼0.61) of experimental group where plasminogen incubated mixed with EACA significantly decreased. EACA was an efficient inhibitor (80% inhibition)
DISCUSSION
In this study, we confirmed the activity of Erysipelothrix rhusiopathiae to recruit host plasminogen and characterized SpaA as an important receptor in the recruitment process. To our knowledge, this is the first report on E. rhusiopathiae recruitment of host plasminogen and the receptor of the process. Our data demonstrated that E. rhusiopathiae could bind host plasminogen and exhibited plasmin activity in the presence of urokinase. Thus, like other pathogenic bacteria, E. rhusiopathiae may exploit the plasminogen/plasmin system as a virulence factor in four aspects: targeting the host fibrinolytic system and degrading fibrin clots, generating bioactive cleavage fragments to influence signaling pathways, activating matrix metalloproteinases to assist in degrading tissue barriers and destroying immune effector molecules for immune evasion (Lahteenmaki, Edelman and Korhonen 2005; Sanderson-Smith et al. 2012; Raymond and Djordjevic 2015) . Thus, plasminogen exploitation may be an important mechanism in E. rhusiopathiae infection process. It should be paid more attention to host plasminogen in future E. rhusiopathiae infection studies.
SpaA has long been known to be a major protective antigen of E. rhusiopathiae, but its roles in virulence have not yet been well clarified (Shi et al. 2013; Harada et al. 2014) . Recent studies demonstrated that SpaA is involved in the adhesion of E. rhusiopathiae to host cells and inhibition of complementmediated killing (Harada et al. 2014; Borrathybay et al. 2015) . Our results demonstrated that SpaA could specifically bind host plasminogen. Anti-SpaA serum could significantly decrease the activity of E. rhusiopathiae to bind plasminogen. Thus, plasminogen receptor was thought to be another virulence role of SpaA. Considering these virulence roles, it is suggested that SpaA should be thought to be an important candidate virulence factor of E. rhusiopathiae. However, the relative contribution of SpaA to E. rhusiopathiae binding activity of plasminogen is still unknown. A SpaA deletion mutant has been reported (Borrathybay et al. 2015) , which would be highly informative for this question.
Lysine residues in receptors often mediate interactions with plasminogen kringle domains (Sanderson-Smith et al. 2012) . It was found that EACA, a lysine analog, was an efficient inhibitor of plasminogen binding to SpaA. Thus, the lysine residues of SpaA play important roles in the binding process. In the future studies, structure of SpaA should be analyzed, which will help to further understand interaction between SpaA and host plasminogen.
In conclusion, our work demonstrated that E. rhusiopathiae could recruit host plasminogen via SpaA. It is necessary to pay more attention to plasminogen receptor and virulence roles of host plasminogen/plasmin system in future E. rhusiopathiae infection studies.
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